PLoS ONE · 2014 · 66 citations · 31 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyRibonucleic Acid (Rna) ChemistryRna Polymerase StructureRna StructureViral StructureAntiviral Drug DesignAntiviral Structure-activity RelationshipsNorovirus GastroenteritisPharmacological PotencyRna-dependent Rna Polymerase FunctionStructure-guided DesignViral Polymerase InhibitorsViral Rna Structure
Noroviruses (NV) are +ssRNA viruses responsible for severe gastroenteritis; no effective vaccines/antivirals are currently available. We previously identified Suramin (9) as a potent inhibitor of NV-RNA dependent RNA polymerase (NV-RdRp). Despite significant in vitro activities versus several pharmacological targets, Suramin clinical use is hampered by pharmacokinetics/toxicity problems. To improve Suramin access to NV-RdRp in vivo, a Suramin-derivative, 8, devoid of two sulphonate groups, was synthesized, achieving significant anti-human-NV-RdRp activity (IC50 = 28 nM); the compound inhibits also murine NV (mNV) RdRp. The synthesis process led to the isolation/characterization of lower molecular weight intermediates (3-7) hosting only one sulphonate head. The crystal structures of both hNV/mNV-RdRps in complex with 6, were analyzed, providing new knowledge on the interactions that a small fragment can establish with NV-RdRps, and establishing a platform for structure-guided optimization of potency, selectivity and drugability.
31
Features and development of <i>Coot</i>
Paul Emsley, Bernhard Lohkamp, W. G. Scott et al. · Acta Crystallographica Section D Biological Crystallography · 2010 · 29.6K citations · Full text
Oliver S. Smart, Thomas Womack, Claus Flensburg et al. · Acta Crystallographica Section D Biological Crystallography · 2012 · 633 citations · Full text